J-shaped association between fasting blood glucose levels and COVID-19 severity in patients without diabetes

By Zhu B, Jin S, Wu L, et al
Published August 24, 2020

Key Takeaways

In this retrospective, multi-centered study of 293 coronavirus disease 2019 (COVID-19) patients without diabetes, researchers intended to determine if there is a connection between fasting blood glucose (FBG) levels and the risk of COVID-19 disease progression, with the goal of providing clinical evidence for glycemic targets in patients. Using the multivariate stepwise binary logistic regression analysis, they tested the dose-response effects of FBG levels on the risk of the severe and critical condition in COVID-19 patients. According to results, FBG levels were plotted in quintiles with set at < 4.74, 4.74-5.21, 5.21-5.78, 5.78-7.05, and ≧7.05 mmol/L. In non-diabetes patients with COVID-19, with nadir at 4.74-5.78 mmol/L, evidence of J-shaped associations between FBG and risk of severe and critical condition was observed.

Read the full article on Diabetes Research and Clinical Practice.

Share with emailShare to FacebookShare to LinkedInShare to Twitter